Targeting glutaminase and mTOR.
Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, Kobe, Japan.
Kazuhiro
K
Tanaka
Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, Kobe, Japan.
Takashi
T
Sasayama
Department of Neurosurgery, Kobe University Graduate School of Medicine and Kobe University Hospital, Kobe, Japan.
Eiji
E
Kohmura
D000818:Animals; D001932:Brain Neoplasms / Q000378:metabolism; D002470:Cell Survival; D015972:Gene Expression Regulation, Neoplastic; D023281:Genomics; D005909:Glioblastoma / Q000378:metabolism; D005972:Glutaminase / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D007527:Isoenzymes; D007668:Kidney / Q000201:enzymology; D008099:Liver / Q000201:enzymology; D051379:Mice; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D040901:Proteomics; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*
D005972:Glutaminase; D007527:Isoenzymes; D019869:Phosphatidylinositol 3-Kinases; D058570:TOR Serine-Threonine Kinases; C546842:MTOR protein, human; C546843:mTOR protein, mouse
glioma; glutaminase; mTOR